|
Market Closed -
NYSE
16:00:02 2026-09-17 EDT
|
5-day change | 1st Jan Change | ||
| 146.73 USD | +0.69% |
|
+21.32% | +51.66% |
| 09-15 | Revvity, Inc. Presents at 2026 Global Healthcare Conference, Sep-15-2026 09:05 AM | |
| 09-14 | Revvity, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 08:30 AM |
Company Valuation: Revvity, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 24,654 | 17,442 | 13,670 | 13,629 | 10,969 | 16,373 | - | - |
| Change | - | -29.26% | -21.63% | -0.3% | -19.52% | 49.27% | - | - |
| Enterprise Value (EV) 1 | 29,020 | 21,382 | 16,656 | 15,617 | 13,269 | 18,358 | 17,832 | 17,251 |
| Change | - | -26.32% | -22.1% | -6.24% | -15.03% | 38.35% | -2.87% | -3.26% |
| P/E | 24.5x | 30.1x | 20x | 50.9x | 46.7x | 61.8x | 48.6x | 35.7x |
| PBR | 3.45x | - | 1.76x | 1.79x | 1.56x | 2.2x | 2.11x | 2x |
| PEG | - | -0.7x | 0.9x | -0.8x | -7.9x | 4.2x | 1.8x | 1x |
| Capitalization / Revenue | 4.86x | 3.78x | 4.97x | 4.95x | 3.84x | 5.74x | 5.45x | 5.13x |
| EV / Revenue | 5.72x | 4.64x | 6.05x | 5.67x | 4.65x | 6.44x | 5.94x | 5.4x |
| EV / EBITDA | 15.8x | 15.1x | 19.9x | 18.4x | 15.7x | 20.3x | 18.5x | 16.4x |
| EV / EBIT | 16.4x | 15.5x | 21.6x | 20x | 17.2x | 22.4x | 20.3x | 18x |
| EV / FCF | 22.1x | 36x | 1,682x | 28.8x | 26x | 32.2x | 28.7x | 26.9x |
| FCF Yield | 4.52% | 2.78% | 0.06% | 3.47% | 3.84% | 3.1% | 3.49% | 3.72% |
| Dividend per Share 2 | 0.28 | - | 0.28 | 0.28 | 0.28 | 0.2888 | 0.2739 | 0.2852 |
| Rate of return | 0.14% | - | 0.25% | 0.25% | 0.29% | 0.2% | 0.19% | 0.19% |
| EPS 2 | 7.99 | 4.58 | 5.55 | 2.2 | 2.07 | 2.372 | 3.018 | 4.107 |
| Distribution rate | 3.5% | - | 5.05% | 12.7% | 13.5% | 12.2% | 9.08% | 6.95% |
| Net sales 1 | 5,070 | 4,611 | 2,751 | 2,756 | 2,856 | 2,852 | 3,004 | 3,193 |
| EBITDA 1 | 1,838 | 1,421 | 836.5 | 847.9 | 843.2 | 902.4 | 966.1 | 1,052 |
| EBIT 1 | 1,771 | 1,381 | 769.9 | 779.5 | 773.5 | 818.5 | 878.4 | 956.2 |
| Net income 1 | 932.2 | 579.2 | 693.1 | 270.4 | 241.2 | 272.9 | 337.4 | 393.3 |
| Net Debt 1 | 4,366 | 3,940 | 2,986 | 1,987 | 2,300 | 1,985 | 1,459 | 877.7 |
| Reference price 2 | 195.36 | 138.08 | 110.77 | 111.99 | 96.75 | 146.73 | 146.73 | 146.73 |
| Nbr of stocks (in thousands) | 126,200 | 126,316 | 123,407 | 121,702 | 113,376 | 111,586 | - | - |
| Announcement Date | 2/1/22 | 2/14/23 | 2/1/24 | 1/31/25 | 2/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 61.42x | 6.4x | 20.22x | 0.2% | 16.26B | |
| 32.22x | 5.65x | 21.67x | 0.28% | 240B | |
| 35.15x | 6.34x | 20.11x | 0.68% | 146B | |
| 41.43x | 10.93x | 24.13x | -.--% | 135B | |
| 16.57x | 3.39x | 11.06x | -.--% | 63.64B | |
| 19.06x | 2.3x | 11.54x | 2.67% | 49.27B | |
| 35.28x | 7.08x | 22.38x | -.--% | 51.46B | |
| 29.94x | 5.94x | 20.16x | 0.67% | 43.33B | |
| 73.29x | 6.98x | 21.29x | -.--% | 41.13B | |
| 46.29x | 7.45x | 26.3x | -.--% | 34.57B | |
| Average | 39.06x | 6.25x | 19.89x | 0.45% | 82.09B | |
| Weighted average by Cap. | 35.56x | 6.53x | 20.48x | 0.4% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- RVTY Stock
- Valuation Revvity, Inc.
Select your edition
All financial news and data tailored to specific country editions
